National Center for Advancing Translational Sciences in Pennsylvania
National Center for Advancing Translational Sciences (93.350) awarded $200 million to recipients in Pennsylvania in 49 grants from fiscal 2021 to 2025, 6.5% of the program's national total. University of Pittsburgh - of the Commonwealth System of Higher Education received the most, $95.3 million.
- Awarded in Pennsylvania$200 million
- Awards49
- Share of the program6.5%
- Rank among states5th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 21 | $37.0 million |
| FY 2022 | 20 | $38.8 million |
| FY 2023 | 22 | $39.7 million |
| FY 2024 | 21 | $39.8 million |
| FY 2025 | 26 | $44.3 million |
Recipients in Pennsylvania
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Pittsburgh - of the Commonwealth System of Higher Education | Other | 15 | $95.3 million |
| The Trustees of the University of Pennsylvania | Colleges and universities | 11 | $67.5 million |
| Pennsylvania State University | Other | 3 | $23.7 million |
| The Children's Hospital of Philadelphia | Nonprofits | 12 | $7.3 million |
| Phrase Health, Inc. | Small businesses | 2 | $3.4 million |
| Captis Diagnostics Inc. | Small businesses | 1 | $1.1 million |
| Advent Therapeutics Inc | Small businesses | 1 | $1.0 million |
| Chemia Biosciences, Inc. | Small businesses | 1 | $317,029 |
| Thomas Jefferson University | Colleges and universities | 1 | $154,761 |
| The Pennsylvania State University | Other | 1 | $40,067 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Pennsylvania?
$200 million from fiscal 2021 to 2025, across 49 awards. Pennsylvania ranks 5th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Pennsylvania?
The largest recipient is University of Pittsburgh - of the Commonwealth System of Higher Education, with $95.3 million in 15 awards. Next are The Trustees of the University of Pennsylvania and Pennsylvania State University.
Can organizations in Pennsylvania apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Pennsylvania
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families
- Children's Health Insurance Program
- Federal Transit Formula Grants
- Special Education Grants to States
- Child Care and Development Block Grant